RecruitingNot ApplicableNCT06292260
Digital Toolkit for Skin Diseases in LMICs: Part 2
Multi-functional Innovative Digital Toolkit for the Skin Diseases n LMICs and Beyond
Sponsor
Tulane University
Enrollment
1,000 participants
Start Date
Mar 18, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Impact evaluation of eSkinHealth in improving case detection of skin NTDs and treatment outcomes in rural and urban settings
Eligibility
Min Age: 18 Years
Inclusion Criteria9
- Healthcare providers (i.e., doctors, nurses, or community health workers/volunteers)
- years or older
- Working at primary health centers or clinics in Cote d'Ivoire
- Able to read and speak fluent French
- Willing to participate in the pilot study for the 12-month study duration
- Willing to use a provided tablet with the eSkinHealth app if they were assigned to the intervention group
- Able to consent for oneself
- Clinically suspected or diagnosed with skin NTDs (Buruli ulcer, leprosy, and yaws) or have other clinically diagnosed skin conditions
- Able to consent for oneself
Exclusion Criteria4
- Planning to leave their job at the clinics within the study period
- Difficulty operating mobile devices
- Patients with skin diseases
- Clinically diagnosed skin conditions outside of the target site
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEmHealth app
The eSkinHealth app is a tablet application that can be used as a portable patient chart for dermatological conditions in areas with poor internet connectivity, and for teledermatology when in need.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06292260
Related Trials
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
NCT056490981 location
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
NCT05723198127 locations
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
NCT074126911 location
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT063876541 location
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT065633232 locations